Literature DB >> 34016183

Genetic susceptibility of COVID-19: a systematic review of current evidence.

SeyedAhmad SeyedAlinaghi1, Mohammad Mehrtak2, Mehrzad MohsseniPour1, Pegah Mirzapour1, Alireza Barzegary3, Pedram Habibi1, Banafsheh Moradmand-Badie4, Amir Masoud Afsahi5, Amirali Karimi6, Mohammad Heydari7, Esmaeil Mehraeen8, Omid Dadras9, Jean-Marc Sabatier10, Fabricio Voltarelli11.   

Abstract

INTRODUCTION: While COVID-19 pandemic continues to spread worldwide, researchers have linked patterns of traits to poor disease outcomes. Risk factors for COVID-19 include asthma, elderly age, being pregnant, having any underlying diseases such as cardiovascular disease, diabetes, obesity, and experiencing lifelong systemic racism. Recently, connections to certain genes have also been found, although the susceptibility has not yet been established. We aimed to investigate the available evidence for the genetic susceptibility to COVID-19.
METHODS: This study was a systematic review of current evidence to investigate the genetic susceptibility of COVID-19. By systematic search and utilizing the keywords in the online databases including Scopus, PubMed, Web of Science, and Science Direct, we retrieved all the related papers and reports published in English from December 2019 to September 2020.
RESULTS: According to the findings, COVID-19 uses the angiotensin-converting enzyme 2 (ACE2) receptor for cell entry. Previous studies have shown that people with ACE2 polymorphism who have type 2 transmembrane serine proteases (TMPRSS2) are at high risk of SARS-CoV-2 infection. Also, two studies have shown that males are more likely to become infected with SARS-CoV-2 than females. Besides, research has also shown that patients possessing HLA-B*15:03 genotype may become immune to the infection.
CONCLUSION: Combing through the genome, several genes related to immune system's response were related to the severity and susceptibility to the COVID-19. In conclusion, a correlation was found between the ACE2 levels and the susceptibility to SARS-CoV-2 infection.

Entities:  

Keywords:  COVID-19; Genetic probability; Genetic susceptibility; Genetic vulnerability; SARS-CoV-2

Year:  2021        PMID: 34016183     DOI: 10.1186/s40001-021-00516-8

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  50 in total

1.  A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.

Authors:  Fereshteh Ghiasvand; Sepideh Zahak Miandoab; Hamid Harandi; Fereshteh Shahmari Golestan; Seyed Ahmad Seyed Alinaghi
Journal:  Infect Disord Drug Targets       Date:  2020

2.  Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital.

Authors:  Fereshteh Ghiasvand; SeyedAhmad SeyedAlinaghi
Journal:  Infect Disord Drug Targets       Date:  2020

3.  Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report.

Authors:  Zahra Ahmadinejad; Faeze Salahshour; Omid Dadras; Hesan Rezaei; SeyedAhmad SeyedAlinaghi
Journal:  Infect Disord Drug Targets       Date:  2021

4.  Prevalence of COVID-19-like Symptoms among People Living with HIV, and Using Antiretroviral Therapy for Prevention and Treatment.

Authors:  SeyedAhmad SeyedAlinaghi; Maryam Ghadimi; Mahboubeh Hajiabdolbaghi; Mehrnaz Rasoolinejad; Ladan Abbasian; Malihe Hassan Nezhad; SeyedAli Dehghan Manshadi; Fatemeh Ghadimi; Zahra Ahmadinejad
Journal:  Curr HIV Res       Date:  2020       Impact factor: 1.581

5.  Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study.

Authors:  SeyedAhmad SeyedAlinaghi; Ladan Abbasian; Mohammad Solduzian; Niloofar Ayoobi Yazdi; Fatemeh Jafari; Alireza Adibimehr; Aazam Farahani; Arezoo Salami Khaneshan; Parvaneh Ebrahimi Alavijeh; Zahra Jahani; Elnaz Karimian; Zahra Ahmadinejad; Hossein Khalili; Arash Seifi; Fereshteh Ghiasvand; Sara Ghaderkhani; Mehrnaz Rasoolinejad
Journal:  Eur J Med Res       Date:  2021-05-06       Impact factor: 2.175

6.  The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.

Authors:  Veronica Mollica; Alessandro Rizzo; Francesco Massari
Journal:  Future Oncol       Date:  2020-07-13       Impact factor: 3.404

7.  Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19).

Authors:  Fereshteh Ghiasvand; Maryam Ghadimi; Fatemeh Ghadimi; Samin Safarpour; Roghieh Hosseinzadeh; SeyedAhmad SeyedAlinaghi
Journal:  IDCases       Date:  2020-05-15

8.  Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.

Authors:  Ehsan Sekhavati; Fatemeh Jafari; SeyedAhmad SeyedAlinaghi; Saeidreza Jamalimoghadamsiahkali; Sara Sadr; Mohammad Tabarestani; Mohammad Pirhayati; Abolfazl Zendehdel; Navid Manafi; Mahboubeh Hajiabdolbaghi; Zahra Ahmadinejad; Hamid Emadi Kouchak; Sirous Jafari; Hosein Khalili; Mohamadreza Salehi; Arash Seifi; Fereshteh Shahmari Golestan; Fereshteh Ghiasvand
Journal:  Int J Antimicrob Agents       Date:  2020-08-25       Impact factor: 5.283

9.  Isolated severe thrombocytopenia in a patient with COVID-19: A case report.

Authors:  Sara Sadr; SeyedAhmad SeyedAlinaghi; Fereshteh Ghiasvand; Malihe Hassan Nezhad; Nina Javadian; Roghieh Hossienzade; Fatemeh Jafari
Journal:  IDCases       Date:  2020-05-29

10.  Cell entry mechanisms of SARS-CoV-2.

Authors:  Jian Shang; Yushun Wan; Chuming Luo; Gang Ye; Qibin Geng; Ashley Auerbach; Fang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-06       Impact factor: 11.205

View more
  28 in total

1.  Will GWAS eventually allow the identification of genomic biomarkers for COVID-19 severity and mortality?

Authors:  Vito Luigi Colona; Michela Biancolella; Antonio Novelli; Giuseppe Novelli
Journal:  J Clin Invest       Date:  2021-12-01       Impact factor: 14.808

2.  Genetic polymorphisms associated with susceptibility to COVID-19 disease and severity: A systematic review and meta-analysis.

Authors:  Cristine Dieter; Letícia de Almeida Brondani; Cristiane Bauermann Leitão; Fernando Gerchman; Natália Emerim Lemos; Daisy Crispim
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

Review 3.  Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.

Authors:  SeyedAhmad SeyedAlinaghi; Pegah Mirzapour; Omid Dadras; Zahra Pashaei; Amirali Karimi; Mehrzad MohsseniPour; Mahdi Soleymanzadeh; Alireza Barzegary; Amir Masoud Afsahi; Farzin Vahedi; Ahmadreza Shamsabadi; Farzane Behnezhad; Solmaz Saeidi; Esmaeil Mehraeen
Journal:  Eur J Med Res       Date:  2021-06-08       Impact factor: 2.175

4.  Update on human genetic susceptibility to COVID-19: susceptibility to virus and response.

Authors:  Vito Luigi Colona; Vasilis Vasiliou; Jessica Watt; Giuseppe Novelli; Juergen K V Reichardt
Journal:  Hum Genomics       Date:  2021-08-25       Impact factor: 4.639

5.  In Silico Molecular Characterization of Human TMPRSS2 Protease Polymorphic Variants and Associated SARS-CoV-2 Susceptibility.

Authors:  Mohd Zulkifli Salleh; Zakuan Zainy Deris
Journal:  Life (Basel)       Date:  2022-02-03

Review 6.  Prenatal and neonatal complications of COVID-19: A systematic review.

Authors:  Zahra Pashaei; SeyedAhmad SeyedAlinaghi; Kowsar Qaderi; Alireza Barzegary; Amirali Karimi; Seyed Peyman Mirghaderi; Pegah Mirzapour; Marcarious M Tantuoyir; Omid Dadras; Zoha Ali; Fabricio Voltarelli; Esmaeil Mehraeen
Journal:  Health Sci Rep       Date:  2022-02-15

Review 7.  Mucormycosis infection in patients with COVID-19: A systematic review.

Authors:  SeyedAhmad SeyedAlinaghi; Amirali Karimi; Alireza Barzegary; Zahra Pashaei; Amir Masoud Afsahi; Sanam Alilou; Nazanin Janfaza; Alireza Shojaei; Fatemeh Afroughi; Parsa Mohammadi; Yasna Soleimani; Newsha Nazarian; Ava Amiri; Marcarious M Tantuoyir; Shahram Oliaei; Esmaeil Mehraeen; Omid Dadras
Journal:  Health Sci Rep       Date:  2022-02-28

8.  Predictors of hospital mortality among patients with COVID-19 in Tehran, Iran.

Authors:  Fatemeh Esfahanian; SeyedAhmad SeyedAlinaghi; Nazanin Janfaza; Marcarious M Tantuoyir
Journal:  SAGE Open Med       Date:  2021-10-13

9.  Whole Exome Sequencing Identifies a Rare Mutation in NACAD as a Possible Cause of COVID Orchitis in Brothers.

Authors:  Rohit Reddy; Iakov Efimenko; Willy Chertman; Taylor Kohn; Parris Diaz; Deepa Seetharam; Kajal Khodamoradi; Eliyahu Kresch; Ranjith Ramasamy
Journal:  Urology       Date:  2021-10-20       Impact factor: 2.649

Review 10.  A Review on Expression, Pathological Roles, and Inhibition of TMPRSS2, the Serine Protease Responsible for SARS-CoV-2 Spike Protein Activation.

Authors:  Jyotirmoy Sarker; Pritha Das; Sabarni Sarker; Apurba Kumar Roy; A Z M Ruhul Momen
Journal:  Scientifica (Cairo)       Date:  2021-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.